EDGAR Filing Documents for 0001144204-16-141020

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001144204-16-141020

Filing Date

2016-12-22

Accepted

2016-12-22 17:00:32

Documents

Effectiveness Date

2016-12-22

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	9882
	Complete submission text file	0001144204-16-141020.txt		11116

Mailing Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170

Business Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170 212-398-4627

Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)